BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15876487)

  • 1. CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.
    Zhenhua L; Tsuchiya N; Narita S; Inoue T; Horikawa Y; Kakinuma H; Kato T; Ogawa O; Habuchi T
    Cancer Lett; 2005 Jul; 225(2):237-43. PubMed ID: 15876487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer.
    Leskelä S; Honrado E; Montero-Conde C; Landa I; Cascón A; Letón R; Talavera P; Cózar JM; Concha A; Robledo M; Rodríguez-Antona C
    Endocr Relat Cancer; 2007 Sep; 14(3):645-54. PubMed ID: 17914095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
    Li Z; Habuchi T; Mitsumori K; Kamoto T; Kinoshitu H; Segawa T; Ogawa O; Kato T
    J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
    Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
    Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.
    Suh JW; Koo BK; Zhang SY; Park KW; Cho JY; Jang IJ; Lee DS; Sohn DW; Lee MM; Kim HS
    CMAJ; 2006 Jun; 174(12):1715-22. PubMed ID: 16754899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between A49T polymorphism of SRD5A2 gene and risk of prostate cancer].
    Tong M; Ai JK; Yuan YM; Yin Y; Zhou LQ; Xin DQ; Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1319-21. PubMed ID: 16029630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
    Tan D; Wu X; Hou M; Lee SO; Lou W; Wang J; Janarthan B; Nallapareddy S; Trump DL; Gao AC
    J Urol; 2005 Aug; 174(2):753-6. PubMed ID: 16006970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
    Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.
    Fukatsu T; Hirokawa Y; Araki T; Hioki T; Murata T; Suzuki H; Ichikawa T; Tsukino H; Qiu D; Katoh T; Sugimura Y; Yatani R; Shiraishi T; Watanabe M
    Anticancer Res; 2004; 24(4):2431-7. PubMed ID: 15330195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.
    Suzuki K; Ohtake N; Nakata S; Takei T; Matsui H; Ono Y; Nakazato H; Hasumi M; Koike H; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
    Anticancer Res; 2002; 22(6B):3507-11. PubMed ID: 12552947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An A/G polymorphism of core 2 branching enzyme gene is associated with prostate cancer.
    Wang L; Mitoma J; Tsuchiya N; Narita S; Horikawa Y; Habuchi T; Imai A; Ishimura H; Ohyama C; Fukuda M
    Biochem Biophys Res Commun; 2005 Jun; 331(4):958-63. PubMed ID: 15882971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.
    Thervet E; Anglicheau D; King B; Schlageter MH; Cassinat B; Beaune P; Legendre C; Daly AK
    Transplantation; 2003 Oct; 76(8):1233-5. PubMed ID: 14578760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
    Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
    Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
    Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
    Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping of the A6986G polymorphism of CYP3A5.
    Weiss J; Haefeli WE
    Br J Clin Pharmacol; 2004 May; 57(5):663; author reply 664. PubMed ID: 15089823
    [No Abstract]   [Full Text] [Related]  

  • 16. Genotyping cytochrome P450 3A5 using the Light Cycler.
    Fredericks S; Moreton M; MacPhee IA; Mohamed M; Marlowe S; Jorga A; Johnston A; Carter ND; Holt DW
    Ann Clin Biochem; 2005 Sep; 42(Pt 5):376-81. PubMed ID: 16168193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
    Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
    Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants in circadian genes and prostate cancer risk: a population-based study in China.
    Chu LW; Zhu Y; Yu K; Zheng T; Yu H; Zhang Y; Sesterhenn I; Chokkalingam AP; Danforth KN; Shen MC; Stanczyk FZ; Gao YT; Hsing AW
    Prostate Cancer Prostatic Dis; 2008; 11(4):342-8. PubMed ID: 17984998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP3A5 polymorphism and sensitivity of blood pressure to dietary salt in Japanese men.
    Zhang L; Miyaki K; Wang W; Muramatsu M
    J Hum Hypertens; 2010 May; 24(5):345-50. PubMed ID: 19812606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
    Paz-y-Miño C; Witte T; Robles P; Llumipanta W; Díaz M; Arévalo M
    Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.